In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy

You are here:
  • Main
  • Publications
  • 2017
  • In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy
< All Topics

Publication:

BMC Immunology 2017: doi.org/10.1186/s12865-017-0193-0

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324274/

Author(s):

María Morales, Mayte Gallego, Victor Iraola, et al.

Quansys Products Used:

ELISA-based Q-Plex™

Abstract:

Allergy to cat epithelia is highly prevalent, being the major recommendation for allergy sufferers its avoidance. However, this is not always feasible. Allergen specific immunotherapy is therefore recommended for these patients. The use of polymerized allergen extracts, allergoids, would allow to achieve the high allergen doses suggested to be effective while maintaining safety.

Previous High Number of Activated CD8+ T Cells Targeting HIV Antigens are Present in Cerebrospinal Fluid in Acute HIV Infection
Next Excessive intake of trans fatty acid accelerates atherosclerosis through promoting inflammation and oxidative stress in a mouse model of hyperlipidemia